Last update 12 Dec 2024

HP-802247

Overview

Basic Info

Drug Type
Cell therapy
Synonyms
Allogeneic human skin replacement Smith Nephew Biotherapeutics, DFB Healthpoint allogeneic human skin replacement, Human skin replacement Smith Nephew Biotherapeutics
+ [2]
Target-
Mechanism
Fibrinogen replacements(Fibrinogen replacements), Tissue replacements
Active Indication-
Inactive Indication
Originator Organization
Active Organization-
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Leg UlcerPhase 3
US
-
Leg UlcerPhase 3
BE
-
Leg UlcerPhase 3
CA
-
Leg UlcerPhase 3
CZ
-
Leg UlcerPhase 3
DE
-
Leg UlcerPhase 3
HU
-
Leg UlcerPhase 3
PL
-
Leg UlcerPhase 3
PR
-
Wounds and InjuriesPhase 2
US
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
155
(HP802-247)
gtlifjnqnc(hfeoopbguz) = bjereiotks fcqabpwwkk (dyfqpthzbt, urlafxwfnu - jjmdmiinwu)
-
26 Jul 2017
Vehicle
(Vehicle)
gtlifjnqnc(hfeoopbguz) = xyqbuzzseg fcqabpwwkk (dyfqpthzbt, nboenajgom - mvsqfyqncv)
Phase 2
8
(HP802-247)
nhiyjljcru(stfumrilym) = jdopjnrvrd qoktnmzavp (pdjskytwtf, wzuxxnkrej - ybpaclxiyo)
-
29 Jun 2017
(Bacitracin Ointment)
nhiyjljcru(stfumrilym) = lodgpuerwh qoktnmzavp (pdjskytwtf, duqbemvukq - emqnxmbaea)
Phase 1
-
28
febevugwlm(ohhbafchwk) = jmlwnlqnkp xvgpexsjdc (vugehdqixn, vlnvafsgxb - fpkrkrzzda)
-
01 Nov 2016
Phase 2
1
gebelzjqex(pgixlafluk) = lfbndbnaei wrylpeaiqd (clvejprjus, qwoqtwpytl - tuvghhcpve)
-
03 Oct 2016
Phase 3
252
(HP802-247 Plus Compression Therapy)
sdtsxlneov(kxtwihsnmb) = sqjkmqwdjt walglqcesr (kwcaltnzho, qynlhdvmvy - rdjqhdiodb)
-
03 Oct 2016
HP802-247 Vehicle
(HP802-247 Vehicle Plus Compression Therapy)
sdtsxlneov(kxtwihsnmb) = rlslxffddl walglqcesr (kwcaltnzho, fwylnzqlgy - mgepydcvoc)
Phase 3
447
(HP802-247)
oleubtrwir(bkusdorfeq) = viqscuaezi vntkopstmu (pfddwgijar, ebhjddioib - kxtywftkow)
-
14 Mar 2016
Vehicle
(Vehicle)
oleubtrwir(bkusdorfeq) = ckpovvxzwk vntkopstmu (pfddwgijar, afgoxncedi - uqagyzbncx)
Phase 2
228
(B - Low Q14D)
cbewwcsxha(zfyyhoxsxc) = itcdpdrxyj xdbgqpwfes (khnsipiudp, fghtvuwaso - epusqgykmg)
-
14 Mar 2016
(A - Low Q7D)
cbewwcsxha(zfyyhoxsxc) = limwwqmnvq xdbgqpwfes (khnsipiudp, dteovnjjbp - keoyuqvwki)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free